Table 2.
ΔTm (K) Variant |
Substrate UDP-Gal |
UDP-Glc | UDP-GlcNAc | Cofactor NAD+ |
NADH |
---|---|---|---|---|---|
WT | −0.3 ± 1.2 | −0.1 ± 0.5 | 2.2 ± 0.3*** | 1.1 ± 0.4** | 0.5 ± 0.5 |
p.K161N | 0.7 ± 0.5 | − 0.4 ± 1.1 | − 0.9 ± 0.3 | 0.6 ± 0.3 | 0.4 ± 0.4 |
p.D175N | 3.0 ± 0.5*** | 3.0 ± 0.5*** | 6.5 ± 0.3*** | 5.5 ± 0.5*** | 4.2 ± 0.4*** |
ΔTm (K) | Substrate & Cofactor | |||||
---|---|---|---|---|---|---|
Variant | NAD+and UDP-Gal |
NAD+and UDP-Glc |
NAD+and UDP-GlcNAc |
NADH and UDP-Gal |
NADH and UDP-Glc |
NADH and UDP-GlcNAc |
WT | 3.4 ± 0.4*** | 3.4 ± 0.4*** | 6.7 ± 0.5*** | 8.3 ± 0.5*** | 8.3 ± 0.4*** | 12.0 ± 0.3*** |
p.K161N | −0.8 ± 1.9 | −0.6 ± 0.6 | −4.8 ± 0.9*** | −0.6 ± 0.5 | −0.3 ± 0.6 | −1.1 ± 0.5 |
p.D175N | 9.1 ± 0.6*** | 9.2 ± 1.9*** | 15.3 ± 0.5*** | 15.6 ± 0.4*** | 15.7 ± 0.6*** | 19.8 ± 0.4*** |
All ligands were added to a final concentration of 1 mM in 10 mM HEPES, pH 8.8. The change of melting temperature, ΔTm, for mutant stability and ligand binding were calculated using equations (2) and (3) respectively.
(2) |
(3) |
Tmand ΔTm values are the means ± SD; n = 3.
p< 0.001,
p < 0.0001 (One way ANOVA with Dunnett comparison test).